Avagliano Mark
G1 Therapeutics, Inc. · Chief Business Officer
Avagliano Mark is listed in public filings as officer: Chief Business Officer. This Avagliano Mark insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include G1 Therapeutics, Inc. (GTHX). Investors use Avagliano Mark's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $186k26k shares | OtherSep 18, 2024 | $1.7M236.6k shares | $7.15 | -- | |
| $089.4k shares | OtherSep 18, 2024 | $265.5K89.4k shares | $2.97 | -- | |
| $041.1k shares | OtherSep 18, 2024 | $235.5K41.1k shares | $5.73 | -- | |
| --26k shares | OtherSep 18, 2024 | Disclosure amount unavailable26k shares | -- | -- | |
| --262.6k shares | Grant / ExerciseSep 18, 2024 | Disclosure amount unavailable20.6k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $607k242k shares | SellJul 5, 2024 | $6.6K2.6k shares | $2.51 | -- | |
| --244.7k shares | Grant / ExerciseJul 1, 2024 | Disclosure amount unavailable35k shares | -- | -- |